Bristol-Myers Squibb
BMY
BMY
2,506 hedge funds and large institutions have $118B invested in Bristol-Myers Squibb in 2022 Q1 according to their latest regulatory filings, with 211 funds opening new positions, 988 increasing their positions, 992 reducing their positions, and 114 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
4.63% more ownership
Funds ownership: 72.11% → 76.74% (+4.6%)
3% more funds holding
Funds holding: 2,436 → 2,506 (+70)
0% less repeat investments, than reductions
Existing positions increased: 988 | Existing positions reduced: 992
Holders
2,506
Holding in Top 10
85
Calls
$2.4B
Puts
$2B
Top Buyers
| 1 | +$1.67B | |
| 2 | +$909M | |
| 3 | +$767M | |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$319M |
| 5 |
Goldman Sachs
New York
|
+$300M |
Top Sellers
| 1 | -$557M | |
| 2 | -$324M | |
| 3 | -$291M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$263M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$200M |